Back to Search
WILLIAM SANDBORN, M.D.
M.D.
Gastroenterology Physician
NPI: 1639157563Individual
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
G63853(CA)
Research & Publications (20)
Evidence-based treatment algorithm for mild to moderate Crohn's disease.
PMID 14697912·Am J Gastroenterol·2003
1-meta
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
PMID 11832465·Gastroenterology·2002
6-review
Transcending conventional therapies: the role of biologic and other novel therapies.
PMID 11380043·Inflamm Bowel Dis·2001
6-review
Assessment of appropriateness of indications for CT enterography in younger patients.
PMID 19637359·Inflamm Bowel Dis·2010
8-other
Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health.
PMID 19610077·Inflamm Bowel Dis·2010
8-other
MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
PMID 19251712·Gut·2009
8-other
Relationship of C-reactive protein with clinical response after therapy with ustekinumab in Crohn's disease.
PMID 19672253·Am J Gastroenterol·2009
3-trial
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
PMID 19653291·Inflamm Bowel Dis·2009
6-review
Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease.
PMID 19542402·AJR Am J Roentgenol·2009
4-observational
Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease.
PMID 19465159·Clin Gastroenterol Hepatol·2009
8-other
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials.
PMID 19392858·Aliment Pharmacol Ther·2009
3-trial
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
PMID 19408340·Inflamm Bowel Dis·2009
3-trial
Adalimumab safety in global clinical trials of patients with Crohn's disease.
PMID 19434735·Inflamm Bowel Dis·2009
8-other
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
PMID 19596014·Gastroenterology·2009
4-observational
Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
PMID 19352339·Am J Gastroenterol·2009
4-observational
Use of azathioprine and 6MP in postoperative Crohn's: changing natural history or just along for the ride?
PMID 19661939·Am J Gastroenterol·2009
8-other
Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.
PMID 19678812·Aliment Pharmacol Ther·2009
2-rct
Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.
PMID 19532125·Am J Gastroenterol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 W ARBOR DR
SAN DIEGO, CA 92103 - Phone
- (800) 926-8273
Quick Facts
- NPI
- 1639157563
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile